Nan Wang photo
Nan Wang
Lawyer
Shanghai
42nd Floor
HKRI Centre One, HKRI Taikoo Hui
288 Shimen Yi Road
Shanghai, 200041
People's Republic of China (PRC)
+86 21 3210 2187
Shanghai
42nd Floor
HKRI Centre One, HKRI Taikoo Hui
288 Shimen Yi Road
Shanghai, 200041
People's Republic of China (PRC)
+86 21 3210 2187

Nan Wang represents clients in cross-border disputes, especially in matters involving multinational companies and state-owned enterprises (SOE) operating in the People’s Republic of China. Ms. Wang also counsels companies in internal investigations stemming from Foreign Corrupt Practices Act (FCPA) allegations and regulatory violations.

Prior to joining Kobre & Kim, Ms. Wang practiced at a global law firm, where she concentrated on commercial litigation and government regulatory investigations. She also worked as a senior adviser on Asia markets at a global consulting firm, advocating on behalf of multinational companies in international trade matters.

Admissions

  • California
  • New York
  • Wisconsin

Education

  • University of Wisconsin Law School, JD
  • East China University of Political Science and Law, LLB

Languages

  • English
  • Mandarin
  • Shanghainese

Select Engagements

  • Representation of an interested party in connection with certain international aspects of a potential PRC Ministry of Commerce (MOFCOM) regulatory investigation into a transaction involving China and Hong Kong operations for over US $2 billion.
  • Representation of a major multinational company in an internal investigation regarding possible fraud and Foreign Corrupt Practices Act (FCPA) issues stemming from its operations in Asia.
  • Representation of a state-owned enterprise (SOE) in China and its subsidiaries in China and the U.S. in defending against a multidistrict product liability class action. 
  • Representation of a state-owned Chinese financial institution in defending against a money laundering and terrorism financing lawsuit filed in the U.S. District Court for the Southern District of New York. 
  • Representation of an international pharmaceutical company in an internal investigation in connection with alleged violations of the FCPA for its sales and marketing practices and third-party agency relationships in China.
 

Publications & Presentations

  • Author, "What China’s Recent ICO Ban Means for Greater-China-Based Virtual Currency Businesses" (Hong Kong Lawyer, October 2017)
  • Co-author, "Of Carrots and Sticks" (India Business Law Journal, January 2017)
  • Co-author, "Investigations in the Middle Kingdom: What Florida Lawyers Need to Know About Internal Investigations in the People’s Republic of China" (International Law Quarterly, January 2017)
  • Co-author, “Clampdown on Multinationals in China Continues” (Corporate Counsel, November 2016) 
  • Co-author, "Get Ready for Disputes As US-China Deals Multiply" (Law 360, June 2016)

Credentials

Admissions

  • California
  • New York
  • Wisconsin

Education

  • University of Wisconsin Law School, JD
  • East China University of Political Science and Law, LLB

Languages

  • English
  • Mandarin
  • Shanghainese

Engagements

  • Representation of an interested party in connection with certain international aspects of a potential PRC Ministry of Commerce (MOFCOM) regulatory investigation into a transaction involving China and Hong Kong operations for over US $2 billion.
  • Representation of a major multinational company in an internal investigation regarding possible fraud and Foreign Corrupt Practices Act (FCPA) issues stemming from its operations in Asia.
  • Representation of a state-owned enterprise (SOE) in China and its subsidiaries in China and the U.S. in defending against a multidistrict product liability class action. 
  • Representation of a state-owned Chinese financial institution in defending against a money laundering and terrorism financing lawsuit filed in the U.S. District Court for the Southern District of New York. 
  • Representation of an international pharmaceutical company in an internal investigation in connection with alleged violations of the FCPA for its sales and marketing practices and third-party agency relationships in China.

Publications & Presentations

  • Author, "What China’s Recent ICO Ban Means for Greater-China-Based Virtual Currency Businesses" (Hong Kong Lawyer, October 2017)
  • Co-author, "Of Carrots and Sticks" (India Business Law Journal, January 2017)
  • Co-author, "Investigations in the Middle Kingdom: What Florida Lawyers Need to Know About Internal Investigations in the People’s Republic of China" (International Law Quarterly, January 2017)
  • Co-author, “Clampdown on Multinationals in China Continues” (Corporate Counsel, November 2016) 
  • Co-author, "Get Ready for Disputes As US-China Deals Multiply" (Law 360, June 2016)